The latest info I have is that the company is 110 percent focused and committed to completing this 10k. I? have no additional information beyond this or knowledge as to the reason for the delay. Nor do I know when it will be published. I will go a bit out on a limb here and say I believe it will be this month in my opinion.
The company has never been this late before and regrets that it has taken this long. The company appreciates the patience and loyalty from our shareholders during this time. Thank you.
Regards, Alan Klitenic Cerebain Biotech Investor Relations 8884302221
Market Data 
Markets 
AI
